H2S Donor, S-Propargyl-Cysteine, Increases CSE in SGC-7901 and Cancer-Induced Mice: Evidence for a Novel Anti-Cancer Effect of Endogenous H2S? by MA, Kaium et al.
H2S Donor, S-Propargyl-Cysteine, Increases CSE in SGC-
7901 and Cancer-Induced Mice: Evidence for a Novel
Anti-Cancer Effect of Endogenous H2S?
Kaium MA
1, Yan Liu
2, Qing Zhu
1, Chun-hua Liu
1, Jun-Li Duan
3, Benny K-H Tan
4, Yi Zhun Zhu
1,4*
1Department of Pharmacology, School of Pharmacy and Institute of Biomedical Sciences, Fudan University, Shanghai, China, 2Department of Cardiovascular Medicine,
Ruijin Hospital of Shanghai Jiaotong University, Shanghai, China, 3Department of Gerontology, Xinhua Hospital, Shanghai Jiaotong University, Shanghai, China,
4Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Abstract
Background: S-propargyl-cysteine (SPRC), an H2S donor, is a structural analogue of S-allycysteine (SAC). It was investigated
for its potential anti-cancer effect on SGC-7901 gastric cancer cells and the possible mechanisms that may be involved.
Methods and Findings: SPRC treatment significantly decreased cell viability, suppressed the proliferation and migration of
SPRC-7901 gastric cancer cells, was pro-apoptotic as well as caused cell cycle arrest at the G1/S phase. In an in vivo study,
intra-peritoneal injection of 50 mg/kg and 100 mg/kg of SPRC significantly reduced tumor weights and tumor volumes of
gastric cancer implants in nude mice, with a tumor growth inhibition rate of 40–75%. SPRC also induced a pro-apoptotic
effect in cancer tissues and elevated the expressions of p53 and Bax in tumors and cells. SPRC treatment also increased
protein expression of cystathione-c-lyase (CSE) in cells and tumors, and elevated H2S levels in cell culture media, plasma and
tumoral CSE activity of gastric cancer-induced nude mice by 2, 2.3 and 1.4 fold, respectively. Most of the anti-cancer
functions of SPRC on cells and tumors were significantly suppressed by PAG, an inhibitor of CSE activity.
Conclusions: Taken together, the results of our study provide insights into a novel anti-cancer effect of H2S as well as of
SPRC on gastric cancer through inducing the activity of a new target, CSE.
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Introduction
S-propargyl-cysteine (SPRC) is a structural analogue of S-
allycysteine (SAC) with the same cysteine-containing structure.
SAC, one of the major compounds in aged garlic extract, is
derived from the degradation of S-alk(en)yl cysteine sulfoxides
(ACSs). This compound has anti-tumor [1][2], anti-bacterial [3],
anti-fungal [4], anti-hepatotoxic [5], cardioprotective properties
[6] and apoptosis [7]. Paclitaxel liposome, a lipid-based formula-
tion of the anticancer drug, paclitaxel, has become a first-line drug
for the treatment of refractory ovarian, breast, stomach and non-
small cell lung cancers. We therefore investigated the in vitro and in
vivo anticancer effects of SPRC and compared these with those of
SAC and Paclitaxel liposome.
Cystathione-c-lyase (CSE) is a member of the trans-sulfura-
tion enzyme family and is responsible for catalyzing the
pyridoxal phosphate-dependent b-disulfide elimination reaction
resulting in ammonium, pyruvate and thiocysteine. Thiocys-
teine may then react with other thiols to generate H2S. The
p53 tumor suppressor protein plays a major role in cellular
response to DNA damage and other genomic aberrations.
Activation of p53 can lead to either cell cycle arrest and DNA
repair or apoptosis. Bax is a key component in cellular
apoptosis through mitochondrial stress while Bcl-2 exerts a
survival function in response to a wide range of apoptotic
stimuli through inhibition of mitochondrial cytochrome c
release. Here for the first time, we found that the anticancer
effects of SPRC involved a hydrogen sulfide (H2S)-mediated
pathway. SPRC can undergo b-elimination by CSE to produce
endogenous H2S, which may up-regulate gene expression of
p53 and Bax, resulting in suppression of cell proliferation and
apoptosis. Our study thus showed a novel anti-cancer effect of
the endogenous H2S donor, SPRC, on gastric cancer through
inducing the activity of a new target, CSE. We demonstrated
for the first time that SPRC was able to suppress cell
p r o l i f e r a t i o na n dm i g r a t i o na n da l s ot u m o rg r o w t hi ng a s t r i c
cancer-induced model of nude mice, indicating that it may be a
potential agent for the treatment of gastric cancer in humans.
Our results showed that the anti-cancer effects of SPRC were
attributed to suppression of cell cycle and induction of
apoptosis. Furthermore, our results also showed that SPRC
could regulate the gene expressions of CSE, Bax and p53. We
found that PAG, an inhibitor of CSE activity, could
significantly suppress the anticancer effects of SPRC.
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Dose-dependent, growth inhibitory and detection of the
cytostatic effects of SPRC on SGC-7901 cells
Effects of SPRC on SGC-7901 gastric cancer cells were shown
in Figure 1A, 1 uM and 10 uM SPRC produced 18–25%
inhibition of viability of SGC-7901 cells. 20 mM to 30 mM
SPRC caused about 50% cell viability inhibition. We also found
that SPRC at low concentrations of 1 uM and 10 uM could
significantly suppress the colony forming and migration ability of
SGC-7901; these effects were more significant compared with
SAC (Figures 1B, 1C and 1D). PAG, an inhibitor of CSE, blocked
the inhibitory effect of SPCR on cell growth (Figures 1B and 1C).
These results indicated that the CSE pathway was involved in
SPRC-induced suppression of cell growth.
Morphological changes, apoptosis and cell cycle analysis
Apoptosis [21] is programmed cell death that is characterized
by specific structural changes that include cell shrinkage, nuclear
condensation and DNA fragmentation. Hoechst staining was used
to observe the morphological changes of cells treated with
Paclitaxel liposome, SPRC and SAC. As shown in Figure 2A,
electron microscopy revealed that morphological changes charac-
teristic of apoptosis occurred in SGC-7901 cells after treatment
with SPRC ed for 24 hours. The cells exhibited a dense staining
pattern with DNA fragmentation and absence of distinct nuclear
membranes. Control cells did not exhibit similar morphological
changes. Apoptosis-inducing effects of SPRC were assessed by flow
cytometry (Figure 2B); 24 hour treatment of SGC-7901 cells with
10 uM SPRC resulted in a significant increase of about 26% of the
apoptotic bodies when compared with the control group. In
Figure 1. Growth inhibition of SGC-7901 cells under SPRC treatment. A. Dose-response study of the effects of SPRC on growth inhibition of
SGC-7901 cells. B. Effects of SPRC, SAC, PAG, PAG+SPRC and paclitaxel liposome on viability of SGC-7901 cells. C. Effects of SPRC, SAC, PAG,
PAG+SPRC and paclitaxel liposome on colony formation in SGC-7901 cells. D. Effects of SPRC, SAC and paclitaxel liposome on migration ability of
SGC-7901 cells. Differential cell migration ability was examined by the wound-closure assay. E. Effects of SPRC, SAC and paclitaxel liposome on
wound closure speed. Values are expressed as % of control. * represent significant difference between control vs. SPRC, SAC and paclitaxel liposome
groups (p,0.01).
# represent significant difference (p,0.01) between SPRC vs SPRC+PAG group (p,0.01).
doi:10.1371/journal.pone.0020525.g001
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liposome and SAC-treated groups were less by about 8% and
4%, respectively.
The effect of SPRC on cell cycle activity of SGC-7901 cells was
analyzed by performing propidium iodide staining followed by
detection with flow cytometry. Consistent with its effect on cell
growth inhibition, SPRC induced cell cycle arrest in SGC-7901
cells at G1/S phase (Figure 2C). 10 uM SPRC also resulted in an
increased accumulation of 24% of cells in the G1 phase and
reduced 20% of cells in the S-phase of the cell cycle, compared to
the control group. This suggests that there is a blockage in the G1/
S phase transition, which may cause cell growth suppression or
apoptosis. The pro-apoptotic effect of SPRC as well as its effect of
cell cycle arrest at G1/S phase was also largely inhibited by PAG.
Effects of SPRC on CSE protein expression and activity
and H2S levels
The expressions of CSE protein in SGC-7901 cells (Figures 3A,
B and C) and tumors in nude mice (Figures 3 D, E and F) were
significantly increased by SPRC treatment. SPRC at doses of
50 mg/kg and 100 mg/kg significantly increased CSE activity by
about 1.4 fold (Figure 3G). CSE activity in tumors of SPRC-
treated nude mice was higher than that in tissues of the SAC-
treated group. H2S levels in cell culture media (Figure 3H), plasma
of nude mice (Figure 3I) were measured. The H2S level in the cell
culture media of 10 uM SPRC-treated cells and the plasma H2So f
50 mg/kg and 100 mg/kg SPRC-treated nude mice were also
significantly increased compared with control group (P,0.05).
When compared with the SAC-treated group of mice, the SPRC-
treated group had significantly higher H2S level (P,0.05). The
elevated levels of CSE protein expression, CSE activity and H2Si n
the SPRC-treated group were all largely reduced by PAG
treatment. The results of these experiments thus suggested that
the anticancer effect of SPRC was mediated by activation of the
CSE/H2S pathway.
Effects of SPRC and SAC on the gene expressions of Bax,
p53 and Bcl-2
The growth-suppression effect of SPRC on SGC-7901 cells was
assessed to analyze the effects on cell cycle activity and expressions
of the apoptosis regulator genes - Bax, p53 and Bcl-2. As shown in
Figure 4A and 4B, we found that 24-hour SPRC treatment
significantly increased the mRNA level (about 1.5 fold) and protein
level of p53 and Bax of SGC-7901 cells.
Growth suppression [22] and induction of cell apoptosis
in tumors by SPRC
The development of gastric cancer evaluated by tumor volume
was significantly reduced by SPRC treatment of 50 mg/kg and
100 mg/kg body weight every other day three times a week with
an IR of 40–75% (Figure 5A and 5B). The tumor weight was also
significantly reduced in SPRC-treated groups (Figures 5C) while
PAG treatment significantly decreased the growth suppression
function of SPRC. The representative tumors in different groups
showed obvious tumor size change (Figures 5D and 5E).
We also examined whether the tumor growth inhibition by
SPRC was reflected in apoptosis of tumor cells. H&E staining
revealed (Figure 5F) more apoptotic tumor cell in paclitaxel
liposome and SPRC-treated groups. TUNEL staining showed that
the tumors from SPRC-treated mice had a markedly higher count
of apoptotic bodies compared with the control tumors (Figure 5G).
The increased incidence of apoptosis in the tumors was in
conformity with the effect of tumor growth inhibition by SPRC,
suggesting that SPRC exerted tumor growth inhibition partly by
augmentation of apoptosis in the tumors.
Effects of SPRC and SAC on the protein and mRNA
expressions [23] of Bax, p53 and Bcl-2
The suppression effect of SPRC on Gastric cancer was further
assessed by Bax, p53 and Bcl-2. This effect of SPRC was also
confirmed in gastric cancer-induced nude mice as shown in
Figures 6A and 6B. The protein and mRNA levels of Bax and p53
in SPRC-treated tumors were significantly increased while those of
Bcl-2 were decreased, compared with control tumors. The
localization and amount of these three proteins in tumor tissues
were also identified by immunostaining. As shown in Figures 6C
and 6D, no obvious immunostaining of the pro-apoptotic proteins,
Bax and p53, was observed in the control group while a strong
signal of immunoreactivity was observed in SPRC- and Paclitaxel
liposome-treated groups. A very weakly positive staining for the
anti-apoptotic protein, Bcl-2, was detected in SPRC-, Paclitaxel
liposome- and SAC-treated groups in Figure 6E. These results
demonstrated that SPRC is able to regulate the gene expressions of
Bax, p53 and Bcl-2 towards cell apoptosis.
H2S demonstrated pro-apoptosis and anti- proliferation
effect on SGC-7901 cells and gastric cancer model of
nude mice
We found that SPRC increased CSE activity and which is
resulting in elevated H2S levels, which in turn modulates gene
expressions of Bax, p53 and Bcl2. Bax is directly induced
mitochondria-driven apoptosis through increased Mt expression
and decreased Bcl-2 expression. The p53 tumor suppressor protein
plays a major role in cellular response to DNA damage and other
genomic aberrations. Activation of p53 leads to either inhibition of
cell proliferation and DNA damage or apoptosis through Bax
protein in Figure 7. These results suggested a novel mechanism for
the anticancer effects of SPRC via CSE/H2S-induced cell growth
inhibition and apoptosis through the p53/Bax pathway.
Discussion
In this study, we have demonstrated a novel anticancer effect of
SPRC on gastric cancer and also provided data to suggest its
possible mechanism. Several new points are generated from our
study. Firstly, we demonstrated that SPRC was able to reduce cell
growth ability significantly and also suppress the migration of
SGC-7901 cells. Secondly, we found that SPRC was able to
increase apoptosis-related morphological changes and induced a
large increase in the percentage of apoptotic cells concurrently
with an obvious cell cycle arrest at G1/S phase. Taken together,
these two findings support evidence for an inhibitory effect of
SPRC on SGC-7901 cells. Thirdly, we further demonstrated that
intra-peritoneal administration of SPRC at doses of 50 and
100 mg/kg body weight every other day three times a week was
Figure 2. Morphological analyses of SGC-7901 cells. A. treatment with SPRC, SAC, PAG, PAG+SPRC and paclitaxel liposome (10 uM) in 24 h for
determination of apoptotic changes analyzed under a fluorescence microscope. B. Analysis of apoptotic cells by Flow cytometric assay. C. Cell cycle
distribution. Markers on pictures indicate: 1, Control. 2, SPRC 10 uM. 3. SAC 10 uM. 4. PAG 10 uM. 5. SPRC+PAG, each 10 uM. 6. Paclitaxel liposome
10 uM.
doi:10.1371/journal.pone.0020525.g002
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Fourthly, we found that SPRC could increase CSE activity and
also its protein expression resulting in elevated H2S levels in cell
culture media and plasma of nude mice. Fifthly, we found that
PAG, an inhibitor of CSE, could largely suppress the above
functions of SPRC. Sixthly, we found that SPRC treatment caused
obvious elevation of mRNA and protein expressions of Bax and
p53.
It has been reported that H2S [24][25][26] can be generated in
gastric cancer cells by the pyridoxal-5-phosphate-dependent
enzyme CSE, for which L-cysteine is the substrate. CSE [27]
could catalyze pyridoxal phosphate-dependent b-disulfide and
elimination reaction, resulting in the formation of ammonium,
pyruvate and thiocysteine. Thiocysteine then reacts with other
thiols to form H2S. PAG has been used in several studies to test the
biological effect of inhibiting endogenous H2S production [28]
SPRC, an analog of SAC has the cysteine-containing structure
which can undergo b-elimination and serve as a substrate of CSE.
The key propargyl group in SPRC might combine with the
activity sites of CSE to increase CSE activity. In our study, obvious
increase in CSE protein expression in gastric cancer cells and
tumors of nude mice was observed in the SPRC-treated group; this
could be explained as a ‘‘compensatory effect’’ to produce H2St o
cope with the apoptosis of cancer cells. Human lung fibroblasts
treated by the H2S donor, NaHS, displayed an increase in DNA
damage, cell cycle arrest and stabilization of p53, coupled with
induction of downstream proteins such as p21, Bax and
cytochrome c [29]. It has been reported that treatment of
pancreatic acinar cells by H2S has been shown to induce
apoptosis, resulting from the activation of caspase 3, decreased
protein level of Bcl-2 and activation of Bax expression. H2S could
also induce apoptosis of insulin-secreting beta cells by enhancing
Figure 4. Effects of SPRC, SAC and paclitaxel liposome on protein expressions of Bax, p53 and Bcl-2 in SGC-7901 cells. A. Lane 1,
paclitaxel liposome 10 uM; Lane 2, control; Lane 3, SPRC 10 uM; Lane 4, SPRC 1 uM; Lane 5, SAC 10 uM; Lane 6, SAC 1 uM. Relative intensity is
calculated by comparing with the intensity of b-actin using densitometry (shown in the graphs on the right). B. Quantification of Bax, p53 and Bcl-2
mRNA expression. * represent significant significance between control vs SPRC, SAC and paclitaxel liposome at p,0.05 level.
doi:10.1371/journal.pone.0020525.g004
Figure 3. Effects of SPRC, SAC, PAG, PAG+SPRC and paclitaxel liposome on CSE protein expressions in SGC-7901 cells (A,B,C);
gastric tumors of nude mice (D,E,F). For A, Lane 1, control group; Lane 2, paclitaxel liposome 10 uM; Lane 3, SPRC 1 uM; Lane 4, SPRC 10 uM;
Lane 5, SAC 10 uM; Lane 6, Control group; Lane 7, SPRC 10 uM; Lane 8, PAG 10 uM; Lane 9, PAG+SPRC 10 uM. For D: Lane 1, control; Lane 2,
paclitaxel liposome 10 mg/kg; Lane 3, SPRC 50 mg/kg; Lane 4, SPRC 100 mg/kg; Lane 5, SAC 100 mg/kg; Lane 6, control; Lane 7, SPRC 100 mg/kg;
Lane 8, PAG 100 mg/kg; Lane 9, PAG+SPRC 100 mg/kg. Relative intensity is calculated by comparing with the intensity of GAPDH using densitometry
(shown in the graphs on the right). * represent significant difference between control vs. SPRC, SAC and paclitaxel liposome treated groups (p,0.05).
# represents significant difference between SPRC 10 uM vs. SPRC+PAG group. Figure G shows CSE activity (mmol/g) in the gastric cancer of all groups.
Figure H shows H2S levels (mM) in cell culture media. Figure I show plasma H2S levels in gastric tumors of nude mice of different groups.
doi:10.1371/journal.pone.0020525.g003
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induces apoptosis by either increasing transcriptional activity of
pro-apoptotic genes such as Bax or suppressing the activity of the
anti-apoptotic gene of Bcl-2 family [31][32]. Bax is also known to
induce mitochondria-driven apoptosis. Here we also found that
activation of CSE and increased H2S levels by SPRC treatment
were coupled with elevated p53 and Bax expressions in gastric cells
and tumors. These results suggested a novel mechanism for the
anticancer effects of SPRC via CSE/H2S-induced cell growth
inhibition and apoptosis through the p53/Bax pathway.
In conclusion, our in vitro and in vivo experimental results
demonstrated that the hydrogen sulfide donor, SPRC, had obvious
inhibitory and pro-apoptotic effects on gastric cancer. SPRC could
increase CSE activity, resulting in an increased level of H2S, which
in turn modulates gene expressions of Bax, p53 and Bcl2.
Methods
All animal experimental protocols complied with the Animal
Management Rules of local authorities and ‘Care and Use of the
Laboratory Animals’ of the Experimental Animal Center of Fudan
University, Shanghai, PRC.
Details of the study approval by ethics committee
Animal Qualification Certificate No.: SCXK hu (Shanghai)
2009-0019
Study approval No.: Fudan University Experimental Animal
ResearchDepartment,ApprovalNo. SYXKhu(Shanghai)2009-0082
Named review board: Chairman: Prof. Yi-zhun ZHU Dean,
School of Pharmacy Fudan Univeristy. Vice Chairman: Prof.
Weiyue Lu, Prof. Wei Wu, Prof. Xun Sun, Prof. Wenjiang Zhou
Figure 5. Effects of intra-peritoneal administration of SPRC, SAC and paclitaxel liposome on gastric cancer growth in male nude
mice. A. Change in average tumor volume (mm
3). B. Inhibition rate (IR) on tumor growth at different days. C. Change in tumor weight. D. Change in
tumor size. E. In vivo tumor imaging of nude mice after treatment for 24 days. * represent significant difference (p,0.05) between control vs. SPRC,
SAC and paclitaxel liposome treated groups.
#represents significant difference (p,0.05) between SPRC 100 mg/kg vs. SPRC+PAG and PAG treated
groups. F. H.E. staining with amplification of 4610 and larger amplified pictures (100610) at right corner. G. Tunnel staining (100610) of apoptotic
bodies of gastric tumors. Number markers on pictures indicate: 1, control group; 2, paclitaxel liposome 10 mg/kg group; 3, SPRC 50 mg/kg group; 4,
SPRC 100 mg/kg group; 5, SAC 100 mg/kg group.
doi:10.1371/journal.pone.0020525.g005
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Prof. Yin geng li, Prof. Hong mei ji, Prof. Li xu yang.
Secretary: Tao lin lin
Chemicals
SPRC was synthesized by reacting L-cysteine with propargyl
bromide. The product was purified by re-crystallization from
ethanol-water. The final product was verified by 1H nuclear
magnetic resonance spectroscopy. SAC was purchased from
Tokyo Kasei (Tokyo, Japan). Paclitaxel liposome was a gift from
Luye Pharma Group Ltd., Singapore. Propargylglycine (PAG) was
purchased from Yinzheng Chemical CO., LTD (Shanghai,
China). MTT (dimethyl thiazolyl tetrazolium bromide) was
purchased from AMRESCO Inc. USA. Hoechst staining, Cell
Cycle and Apoptosis analysis Kits were purchased from Beyotime,
China. RPMI 1640 medium were purchased from GIBCO
TM
Invitrogen, USA. Rabbit polyclonal antibodies to Bax, P53 and
Bcl2 were purchased from Cell Signaling, USA and goat
polyclonal antibody to CSE from Santa Cruz, USA. SuperScript
II RT kit and SYBR Green PCR Master Mix were purchased
Figure 6. Effects of 24-day treatment with SPRC, SAC and paclitaxel liposome on Bax, p53 and Bcl-2 in gastric cancer-induced nude
mice. A. protein expression, Lane 1 control; Lane 2 paclitaxel liposome 10 mg/kg; Lane 3 SPRC 50 mg/kg; Lane 4, SPRC 100 mg/kg; Lane 5, SAC
100 mg/kg. Relative intensity was calculated by comparing with the intensity of b-actin using densitometry. B. mRNA expression. *represent
statistical significance between control vs SPRC, SAC and paclitaxel liposome- treated groups (p,0.05). C. Immunohistochemical staining of pro-
apoptotic protein, Bax. D. Immunohistochemical staining of pro-apoptotic protein, p53. E. Immunohistochemical staining of pro-apoptotic protein,
Bcl-2. Number markers on pictures in Figure 6 C, D and E indicate: 1, control group; 2, paclitaxel liposome 10 mg/kg; 3, SPRC 50 mg/kg; 4, SPRC
100 mg/kg; 5, SAC 100 mg/kg.
doi:10.1371/journal.pone.0020525.g006
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CALBIOCHEM, Germany.
Cell line and culture
Human gastric carcinoma (SGC-7901) cells were obtained from
Cell Bank of Shanghai Institute for Biological Sciences, China and
cultured in RPMI 1640 medium with 10% fetal bovine serum
(FBS), 100 U/mL penicillin and 100 mg/mL streptomycin in
culture flasks at 37uC in humidified 5% CO2 incubator. The cells
were fed until confluence and expanded by trypsinization and sub-
cultured at lower numbers in new culture flasks.
MTT assay
MTT (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide) assay was perform e db yu s i n gt h em e t h o do f
Arumugam et al. [8] with slight modifications. Briefly, cells in
suspension containing approximately 8,000 to 10,000 cells were
added to each well of a 96-well culture plate and incubated for
24 h at 37uC in a humidified atmosphere of 95% air and 5%
CO2. SPRC, SAC and Paclitaxel liposome were dissolved in
culture medium and added to the cells in 96-well plates. 10 final
concentrations of SPRC (1 uM, 10 uM, 100 uM, 1 mM, 5 mM,
10 mM, 15 mM, 20 mM, 25 mM and 30 mM), SAC (1 uM and
10 uM) and Paclitaxel liposome (10 uM) were added to the cells
to study their effects on cell viability. The effect of combined
treatment of 10 uM SPRC and 10 uM PAG was also studied.
After 24 hours, 100 mL of 1 mg/ml MTT solution was added to
each well and re-incubation followed for 4 hours. 100 mL
DMSO was then added after removal of MTT solution and the
plates were shaken for 10 minutes. The optical density of 96-
well culture plates was measured using an enzyme-linked
immunosorbent assay (ELISA) reader. The optical densities
from the treated wells were converted to a percentage of living
cells (‘‘cell survival rate’’) against the control using the following
formula:
Absorbance of treated cells in each well|100=
Mean absorbance of control cells:
Colony-forming assay
Colony forming experiment was performed according to the
method of Wang et al. (1998, 2003) [9][10]. The single cell
suspension was produced and cultured in 12-well plates at a
density of 150 cells per well. After 24 hours of planting, 2
concentrations of SPRC (10 uM, 1 uM) and SAC (10 uM, 1 uM)
were added. An experiment with combined treatment of 10 uM
SPRC and 10 uM PAG was also studied. Cells were incubated for
6 days. The cells were then fixed in 70% ethanol and stained with
1% Giemsa blue. The colonies that consisted of .50 cells were
scored and compared with the normal control group. Each
experiment was repeated three times.
Figure 7. H2S demonstrated pro-apoptosis and anti- proliferation effect on SGC-7901 cells and gastric cancer model of nude mice:
SPRC increased CSE activity and which is resulting in elevated H2S levels. The increase levels of H2S have turned modulates Bax, p53 and
Bcl2 protein and mRNA expression. Bax has induced apoptosis through Mt and Bcl-2 expression. p53 leads to either inhibition of cell proliferation and
DNA damage or apoptosis through Bax protein.
doi:10.1371/journal.pone.0020525.g007
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Apoptosis [11][12] was determined using a Hoechst Staining
Kit (Beyotime). SGC-7901 cells were treated with SPRC (10 uM),
SAC (10 Um), Paclitaxel liposome (10 uM) and combined SPRC
and PAG (each 10 uM) for 24 hours. The cells were rinsed twice
in PBS and then fixed for 10 minutes at 4uC and then stained by
karyophilic dye, Hoechst 33258, for 5 minutes. After a final rinse
in PBS, the cells were mounted in moiwol, an anti-fade agent, and
visualized under ultraviolet light with a fluorescence microscope.
Because this dye stains both apoptotic and non-apoptotic cells,
apoptotic cells were identified as those displaying chromatin
condensation and nuclear fragmentation.
Flow cytometric analysis of cell cycle phase distribution
and detection of apoptosis
All cells were first plated at a density of 2.5610
5 cells/well in 6-
well plates. After incubating with SPRC, SAC, Paclitaxel liposome
and combined SPRC and PAG treatment for 24 hours, the cells
were detached and collected into flow cytometry tubes and
centrifuged at 1000 rpm for 5 min to obtain a cell pellet.
Apoptosis assay
The cells were stained using the cell apoptosis detection Kit
(Beyotime) according to the manufacturer’s instructions. The cell
pellet was washed twice with PBS. 16Binding buffer was added to
1610
6 cells/ml, and PI was then added in the dark. After
incubation for 30 min in the dark, the cells were immediately
analyzed using Cyan flow cytometer (BD FACSCalibur) and
ModFit software.
Cell cycle analysis
Cell cycle analysis was performed by the method of Herman-
Antosiewicz et al [13]. Briefly, cells were incubated in culture
media alone and culture media containing SPRC, SAC and
Paclitaxel liposome (10 uM) at 37uC for 24 h. Cells were washed
by cold PBS, fixed in 70% ethanol, and stored at 4uC for
subsequent cell cycle analysis. Fixed cells were washed with PBS
once, then re-suspended in 1 mL of PI staining reagent (50 mg/ml
propidium iodide and 1 mg/ml RNAse in 1 ml of sodium citrate
buffer, pH 7.4). Samples were incubated in the dark for 30 min
before cell cycle analysis. The distribution of cells in the cell cycle
was measured by Cyan flow cytometer (BD FACSCalibur) analysis
system and quantitation of cell cycle distribution was performed
using Multi-cycle Software (ModFit software). The percentage of
cells in G1, S and G2 phases were calculated.
Wound healing assay
Cells were seeded into 6-well culture plates and allowed to grow
to 90% confluence. Similar sized wounds were introduced to
monolayer cells using sterile pipette tips. Wounded monolayer cells
were washed 3 times by PBS to remove cell debris; SPRC and
SAC were then added at two concentrations (1 uM, 10 uM) and
paclitaxel liposome (10 uM). The speed of wound closure was
monitored and photographed after 12 and 24 hours. The
comparative speed of wound closure of treated cells against the
control was calculated using the following formula: (the wound
width of treated cells at 0 hour - the wound width at 24 hours)/
(the wound width of Control cells at 0 hour - the wound width at
24 hours)6100.
Quantitative real-time PCR
Total RNA was reverse transcribed using a SuperScript II RT
kit (Takara, Japan) primed with oligo (dT). Expressions of Bcl2,
Bax and P53 mRNA were examined by real-time PCR with Step
One PCR system (Applied Biosystems). 2 ul of reverse transcribed
cDNA product was added in a 20 ul reaction mixture containing
10 ul SYBR Premix EX Taq (26), 0.4 ul ROX Reference Dye
(506), 0.4 uM forward primer and 0.4 uM reward primer. The
cycling conditions were as follows: pre-incubation at 95uC for 30 s,
followed by 40 cycles of denaturation at 95uC for 5 s, annealing
and extension at 60uC for 31 s. At the completion of cycling,
melting curve analysis was performed to establish the specificity of
the PCR product. The relative quantitative value was expressed by
the DDCT method. Control was used as the reference sample and
b-actin was used as the endogenous control. Each experiment was
performed in duplicate and repeated three times. The primer
sequences and expected product size were as follows: Human b-
actin: forward, 59-CGTGGACATCCGCAAAG-39 and reverse,
59-TGGAAGGTGGACAGCGA-39 (201 bp); human Bax: for-
ward, 59-ATGCGTCCACCAAGAAGC-39 and reverse, 59-GT-
CCACGGCGGCAATCA-39 (95 bp); human bcl2: forward, 59-
AACTGGGGGAGGATTGTG-39 and reverse, 59-AGGTGCC-
GGTTCAGGTAC-39 (128 bp); human p53: forward, 59-AC-
CACCATCCACTACAACTA-39 and reverse, 59-AAACACGC-
ACCTCAAAGC-39 (136 bp).
Western blot analysis
Cells were plated to dishes and treated with SPRC (1 uM,
10 uM), SAC (1 uM, 10 uM) and Paclitaxel liposome (10 uM) for
24 hours. After 24 hours of treatment, the cells were washed twice
with cold PBS. The cells from each sample were solubilized in
RIPA buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1%
NP40, 0.1% SDS, 10 mM sodium deoxycholate, 1 mM phenyl-
methyl-sulfonylfluoride) and kept on ice for 30 minutes. Cells
lysates were centrifuged at 10,000 g at 4uC for 10 min and the
supernatants were stored at 270uC until assay. Protein concen-
tration was measured by the Bradford method. 25 ml protein for
each group mixed with 5 ml loading buffer were separated by 10%
SDS-polyacrylamine gel and transferred to polyvinylidene fluoride
membranes [14]. The membranes were blocked for 2 hours in 5%
skim milk powder in Tris-buffer saline containing 0.05% Tween
20 (TBST) at room temperature. The resulting blots were then
probed with polyclonal CHT (cystathionine c-lyase)/CSE Ab
(1:500, Santa Cruz, USA), polyclonal Bcl-2 Ab (1 : 1000, Cell
Signaling, USA), polyclonal Bax Ab (1 : 1000, Cell Signaling,
USA) and polyclonal p53 Ab (1 : 500, Cell Signaling, USA) for
overnight at 4uC. Membranes were washed for three times with
TBST for 10 minutes each and incubated for 2 h with the anti-
rabbit (for Bax, p53 and Bcl-2 Ab) and anti-goat (for CSE Ab)
secondary antibody at room temperature (1: 2000, Santa Cruz,
CA), again followed by three times washing with TBST for
10 minutes each. The immunoreactive proteins were detected
using the ECL Western blotting detection system (Alpha Imaging
Inc., USA), according to the manufacturer’s instructions. To
measure the expression of each gene, the relative intensity was
calculated by comparing with the intensity of b-actin (for Bax, p53
and Bcl-2) and GAPDH (for CSE) using densitometry.
Measurement of human and mouse plasma H2S
concentration
To measure H2S concentration, 500 mL of culture media from
each group (n=6, 1610
6 cells per sample), 75 mL of plasma of
nude mice (n=6) and 75 mL of plasma of gastric cancer patients
(n=3) and 425 mL of distilled water were added to a micro-tube
containing zinc acetate (1% w/v; 250 mL). Subsequently, N,N-
dimethyl-p-phenylenediamine sulphate (NNDPD, 20 mM; 133 mL)
in 7.2 M HCl was added, then followed by FeCl3 (30 mM; 133 mL)
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then used to participate any protein. This optical absorbance of
the resulting solution was measured at 670 nm using a 96-well
microplate reader (Tecan Systems Inc., Switzerland).
Establishment of human gastric cancer model in nude
mice
Male nude mice, aged 3–4 weeks, weighed 18–20 g, were
purchased from Animal Experiment Center (Shanghai Institute for
Biological Sciences, China) and bred in specific pathogen-free
(SPF) conditions, housed in mesh cages under controlled
conditions of temperature (2363uC) and relative humidity
(50620%), with 10–15 air changes per hour and light illumination
for 12 hours a day. The animals were allowed access to food and
purified water ad lib.
Injections of 200 mL( 1 610
7 SGC-7901 cells) per site were made
into the flanks of nude mice to establish a model of tumor-bearing
mice [15] [16]. About 25 days post-implant, the bearing-tumors
were extracted. After necrotic tissue and non-cancerous tissues of
the specimens were removed, the remaining cancerous tissues
were cut into small pieces of about 1 mm
3 in size. The gastric
tumor models were established by implanting tumor bits directly
to the flanks of nude mice. 7 days post-implant, when the diameter
of the tumor had reached about 0.3–0.5 cm, the tumor-induced
nude mice were divided into a control group (n=5), paclitaxel
liposome (10 mg/kg)-treated group (n=5), SPRC (50 mg/kg and
100 mg/kg)-treated groups (each n=8), SAC (50 mg/kg and
100 mg/kg)-treated groups (each n=8) and combined treatment
group of SPRC (100 mg/kg)+PAG (100 mg/kg) (n=8). All the
mice were injected intra-peritoneal every other day with 100 ul of
the respective drugs in the different treatment groups while sterile
water was injected into the control group.
General observation and tumor measurements
The general condition of the mice was observed every day.
Nude mice were weighed and the sizes of tumors were measured
every 7 days. The size of each tumors was first measured for its
length (L) and width (W); the volume was then calculated, using
the formula V=W
26L60.5, where L is the longest diameter and
W the shortest width. The tumor growth inhibition rate (IR) was
calculated according to the volume of the tumor: IR (%)=(12vol-
ume of treated group/volume of control group)6100%. The
experiments were terminated and the mice sacrificed by cervical
decapitation 24 days after treatment. The tumors harvested at
autopsy [17] were weighed and sectioned, and fresh tissue samples
were wrapped in aluminum foil and immediately frozen in liquid
nitrogen [18]. All animal procedures were performed according to
standard protocol and in accordance with the standard recom-
mendations for the proper care and use of laboratory animals.
H.E and TUNEL staining
Cell apoptosis and necrosis were examined by H.E and Tunnel
staining. The frozen samples of gastric tumor growth were cut into
5 mm-thick sections, mounted on 3-aminopropyltriethoxysilane
(APES)-treated slides. Slides were fixed with 4% paraformalde-
hyde solution. The slides were observed and imaged by an
Olympus DP72 microscopic camera and analyzed by Image Pro 7
software.
Real time PCR, western blot and immunohistochemistry
analysis
We analyzed the protein level of CSE, Bax, p53 and BCL-2 in
tumor tissues (western blot methods [19] as described in protocol
1). For immunohistochemistry staining, the slides of tumor tissue
were blocked by ass serum for 1 h at room temperature and
incubated with rabbit anti-Bax, anti-p53, and anti-Bcl2 (1:1000,
cell signal) overnight at 4uC, then incubated with anti-rabbit
secondary antigen for 1 h at room temperature and stained.
Between each step, the slides were washed 36 with PBS. The
slides were observed and imaged by an Olympus DP72
microscopic camera and analyzed by Image Pro 7 software.
mRNA levels of Bax, p53 and Bcl-2 were also evaluated by
realtime-PCR (methods, primer sequence and expected products
size were the same as in protocol 1).
Measurement of CSE activity
CSE activity was assayed as described previously. Briefly, 0.1 g
of tumor tissues (n=6 per group) was thawed on ice and
homogenized in 2 mL of 100 mM ice-cold potassium phosphate
buffer (pH 7.4). Tissues homogenates were centrifuged at 12,000 g
for 10 minutes at 4uC, and the supernatant was then used for the
assay. The reaction mixture contained 20 mLo f1 0 m ML -
cysteine, 20 mL of 2 mM pyridoxal-5-phosphate, 30 mL of PBS,
and 430 mL of tissue homogenate. The catalytic reaction was
initiated by transferring the reaction mixture from ice to a 37uC
water bath for 30 minutes. Then 250 mL of 1% zinc acetate was
added to the tubes using a syringe to trap the evolved H2S. Next,
250 mL of 10% TCA was added to quench the enzymatic reaction.
Finally, 133 mL of NNDPD in 7.2 M HCl and 133 mL of FeCl3 in
1.2 M HCl were added. The absorbance of the final reaction
mixture was measured at 670 nm using a 96-well microplate
reader (Tecan System Inc., Switzerland). All samples were assayed
in duplicate, and the H2S concentration for each sample was
calculated against a calibration curve using NaHS (3.125 mM
2250 mM). Results were expressed as mmol/g. Protein content
was determined by using a BCA assay kit (Beytime Biotechnology,
China).
Statistical analysis
All values were presented as means and standard deviations.
One-way analysis of variance (ANOVA) was used to examine
statistical comparisons between groups. The statistical significance
of difference between two groups was determined using two-tailed
Student’s t-test [20]. A probability value of ,0.05 was taken to
indicate statistical significance. All analyses were performed using
SPSS 12.0.
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